AI tailors blood pressure drugs, outsmarting One-Size-Fits-All medicine

NCT ID NCT04223934

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence system called optima4BP can improve blood pressure control in people with hypertension. The AI analyzes a patient's medications and recommends the best drug adjustments—adding, removing, replacing, or changing doses. Researchers will compare the AI-guided approach to standard care over six months, measuring blood pressure changes and side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an artificial intelligence clinical decision support system called optima4BP that recommends blood pressure medication adjustments
What this could lead to
If successful, this AI tool could help doctors personalize hypertension treatment more effectively, potentially lowering blood pressure and reducing heart risks.
What could go wrong
This is a relatively small study, and the AI recommendations still require doctor approval. The tool may not work for everyone or may lead to more side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California San Francisco

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.